Health Care & Life Sciences » Pharmaceuticals » Top pharmaceutical drugs | Top women's health products by revenue U.S. 2016

Revenue from top 20 women health products in the United States 2016

Top 20 health products for women in the U.S. based on revenue in 2016 (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data shows the top 20 products for women's health based on revenue in the U.S. generated during 2016. In that year, NuvaRing from Merck generated some 576 million USD in revenues. Contraceptives have become much more affordable in the U.S. as there are no longer patents that prevent a combined use of estrogen and progesterone for oral contraception. Both of these hormones are easy to synthesize and manufacture.

Prolia (Amgen)	1049
Premarin (Pfizer)	956
Mirena (Bayer)	776
Forteo (Eli Lilly)	771
NuvaRing (Merck)	576
Nexplanon (Merck)	420
Lo Loestrin Fe (Allergan)	404
Estrace Cream (Allergan)	379
Makena (AMAG Pharm.)	334
Minastrin 24 FE (Allergan)	326
Vagifem (Novo Nordisk)	302
Lupron (AbbVie)	285
Gonal-F (Merck KGaA)	221
Follistim (Merck)	157
Yasmin (Bayer)	142
Oral contrception franchise (J&J/Pfizer)	129
Natazia (Bayer)	104
Minivelle (Hisamitsu)	88
Caltrate (Pfizer)	87
Junel/Loestrin (Teva)	79

Revenue from top 20 women health products in the United States 2016

StatInvestor